Gennex Laboratories Ltd share price logo

Gennex Laboratories Ltd Share Price (531739)

Check the latest share price of Gennex Laboratories Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹13.040.31%

as on 04:01PM, 13 Jun 2025

BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Gennex Laboratories Ltd Stock Performance

Get live Gennex Laboratories Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹12.75
    Day's Price Range
    ₹13.09
  • 52 Week's Low

    52 Week's High

    ₹11.15
    52-Week Price Range
    ₹29
1 Month Return-0.76 %
3 Month Return-14.08 %
1 Year Return-22.39 %
3 Year Return+ 103.12 %
5 Year Return+ 198.85 %
Previous Close₹13.08
Open₹12.80
Volume1.58L
Upper Circuit₹15.69
Lower Circuit₹10.47

Gennex Laboratories Ltd Fundamentals & Key Indicators

Check Gennex Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹295.68 Cr

Return on Equity (ROE)

9.45

PE Ratio (TTM)

17.11

Return on capital employed (ROCE)

12.5

Industry PE ratio

57.39

Beta (LTM)

1

P/B Ratio

2.18

Dividend Yield

0

PEG Ratio

142.54

Quarterly Earnings Growth YOY

-31.78

EPS (TTM)

0.58

Sector

Pharmaceuticals

Book Value

7.24

Technical Analysis

How to invest in Gennex Laboratories Ltd?

Investing in Gennex Laboratories Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Gennex Laboratories Ltd or 531739 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Gennex Laboratories Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Gennex Laboratories Ltd with just a few clicks!

Gennex Laboratories Ltd Stock's Interest Amongst Investors

28%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Search interest for Gennex Laboratories Ltd Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Gennex Laboratories Ltd Valuation

Track how Gennex Laboratories Ltd P/E has moved over time to understand its valuation trends.

Gennex Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (10.10x)

March 23, 2020

Today (17.11x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (86.13x)

August 3, 2018

LowHigh

Today’s Price to Earnings Ratio: 17.11x

Gennex Laboratories Ltd Financial Results

Get the annual and quarterly financial summary of Gennex Laboratories Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

34 (0%)28 (15%)32 (11%)38 (20%)40 (7%)
Net Income

(in ₹ Cr)

4 (0%)5 (4%)5 (15%)5 (6%)3 (39%)
Net Profit Margin13.43% (0%)16.45% (22%)17.02% (3%)13.44% (21%)7.61% (43%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

60 (0%)69 (15%)96 (40%)205 (113%)
Total Liabilities

(in ₹ Cr)

20 (0%)25 (26%)17 (30%)35 (101%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

0 (0%)-1 (0%)7 (561%)-14 (318%)-33 (131%)

Gennex Laboratories Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Gennex Laboratories Ltd.

  • Gennex Laboratories Ltd Earnings Results

    Gennex Laboratories Ltd’s net profit fell -48.44% since last year same period to ₹2.32Cr in the Q4 2024-2025. On a quarterly growth basis, Gennex Laboratories Ltd has generated -50% fall in its net profits since last 3-months.

    Read More about Earnings Results

Gennex Laboratories Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Gennex Laboratories Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
18.42%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
81.58%
0.00
Others
0%
0.00

Gennex Laboratories Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Gennex Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA295.6839.77%0.511386
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245

Insights on Gennex Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 30.79 Cr → 44.16 Cr (in ₹), with an average increase of 11.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 67.7%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 81.58% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 18.42% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 27.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 4.83 Cr → 2.32 Cr (in ₹), with an average decrease of 27.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, Gennex Lab. stock has moved down by -14.1%

About Gennex Laboratories Ltd

Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates. Incorporated as a private limited company on 25th June 1985, the company was converted into a public limited company in 1995. Located in Andhra Pradesh, India, its export list includes countries like Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and others. The company maintains a well-managed team at all stages of operations and has adopted GMP Good Manufacturing Practices in the year 2005-06. During 2006-07, the company installed Separate Air Handling System in final drug isolation area and also in drying and packing area to align with CGMP as per ICH/WH0 guidelines. In 2007-08, the company diversified into the business of Biotech product, while also changing its name from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited.

Revenue: ₹40.33Cr as on March 2025 (Q4 FY25)
Net Profit: ₹3.07Cr as on March 2025 (Q4 FY25)
Chairperson Name: Arihant Baid
OrganisationGennex Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOArihant Baid
E-voting on sharesClick here to vote

FAQs

What is Gennex Laboratories Ltd share price today?

Gennex Laboratories Ltd share price today stands at ₹13.04, Open: ₹12.8, Previous Close: ₹13.08, High: ₹13.09, Low: ₹12.75, 52 Week High: ₹29, 52 Week Low: ₹11.15.

What is today's traded volume of Gennex Laboratories Ltd?

Today's traded volume of Gennex Laboratories Ltd is 1.58L. Which means that 1.58L shares of Gennex Laboratories Ltd were bought and sold on the stock market during today's trading session.

What is Gennex Laboratories Ltd's market cap today?

Today's market capitalisation of Gennex Laboratories Ltd is ₹295.68 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Gennex Laboratories Ltd?

Gennex Laboratories Ltd’s 52 week high is ₹29 and 52 week low is ₹11.15. The current share price of Gennex Laboratories Ltd is ₹13.04, which is -55.03% down from its 52 week high and 16.95% up from its 52 week low.